Cyclic peptides as selective tachykinin antagonists

J Med Chem. 1993 Jan 8;36(1):2-10. doi: 10.1021/jm00053a001.

Abstract

Twenty homodetic cyclic peptides based on the C-terminal sequence of substance P were prepared (Table I) by a combination of solid-phase techniques and cyclizations using azide coupling procedures. Incorporation of dipeptide mimics based on substituted gamma-lactams were used in some cases to restrict their conformational mobility. Five of these cyclic peptides were shown to have high tachykinin antagonist activity (pA2 > 6) at NK-2 receptors (rat vas deferens). The two most potent of this series, XVII, cyclo(Gln-Trp-Phe-Gly-Leu-Met) (pA2 = 8.1), and I cyclo(Gln-Trp-Phe(R)Gly[ANC-2]Leu-Met) (pA2 = 6.7), were selective for NK-2 receptors compared with the other tachykinin receptors (Table II).

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Guinea Pigs
  • Male
  • Molecular Sequence Data
  • Peptides, Cyclic / chemical synthesis*
  • Peptides, Cyclic / chemistry
  • Peptides, Cyclic / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Neurokinin-2
  • Receptors, Neurotransmitter / drug effects
  • Structure-Activity Relationship
  • Substance P / analogs & derivatives
  • Tachykinins / antagonists & inhibitors*
  • Vas Deferens / drug effects

Substances

  • Peptides, Cyclic
  • Receptors, Neurokinin-2
  • Receptors, Neurotransmitter
  • Tachykinins
  • Substance P